The presence of specific antibodies against human polyomavirus 12, Saint Louis polyomavirus and New Jersey polyomavirus was investigated by using virus-like particle-based ELISAs with serum samples from 706 Italians aged 1- to 100-years-old. The findings indicate that these polyomaviruses circulate widely in humans, with peak seroprevalence, observed at adulthood, of 97.3%, 93.3%, 57.5%, for human polyomavirus 12, Saint Louis polyomavirus and New Jersey polyomavirus, respectively.

Age-specific seroprevalence of human polyomavirus 12 and Saint Louis and New Jersey polyomaviruses

Fernanda Martini
Membro del Collaboration Group
;
Mauro Tognon
Penultimo
Membro del Collaboration Group
;
2018

Abstract

The presence of specific antibodies against human polyomavirus 12, Saint Louis polyomavirus and New Jersey polyomavirus was investigated by using virus-like particle-based ELISAs with serum samples from 706 Italians aged 1- to 100-years-old. The findings indicate that these polyomaviruses circulate widely in humans, with peak seroprevalence, observed at adulthood, of 97.3%, 93.3%, 57.5%, for human polyomavirus 12, Saint Louis polyomavirus and New Jersey polyomavirus, respectively.
2018
Gaboriaud, Pauline; Ferté, Marion; Arnold, Françoise; Leblond, Valérie; Nicol, Jérôme; Debare, Heloïse; Le Meur, Mélanie; Martini, Fernanda; Tognon, M...espandi
File in questo prodotto:
File Dimensione Formato  
HPyV 12 EMI 2018.pdf

accesso aperto

Tipologia: Full text (versione editoriale)
Licenza: Creative commons
Dimensione 404.95 kB
Formato Adobe PDF
404.95 kB Adobe PDF Visualizza/Apri

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2384851
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 12
social impact